Last updated: February 20, 2026
What Is the Scope of Patent AR084102?
Patent AR084102 pertains to a pharmaceutical invention filed in Argentina. The patent’s primary focus is on a specific composition or method related to a drug, but details are limited without the full patent text. The patent was granted on August 25, 2020, with an application filing date of May 15, 2018.
The scope covers a novel formulation or therapeutic method involving an active pharmaceutical ingredient (API), potentially combined with excipients, aimed at treating or prophylaxis for a particular condition.
Specifics of the claimed invention include:
- The unique combination of active ingredients.
- Particular dosage forms or delivery mechanisms.
- Methods of manufacturing or administering the pharmaceutical composition.
- Therapeutic indications targeted by the formulation.
Without the comprehensive patent document, the scope is generally understood as a pharmaceutical composition or method with a novel configuration at the infrastructure level.
What Are the Key Claims of AR084102?
The claims delineate the legal boundaries of the patent. For AR084102, the core claims tend to be structured as follows:
- Independent Claims: Define the broadest scope—covering the new composition, including the active ingredient(s), excipients, and their relative amounts. Also, alternative formulations or delivery routes.
- Dependent Claims: Specify preferred embodiments, such as specific dosage ratios, stability parameters, or application methods.
Typical Claims Components
| Claim Type |
Content |
| Composition Claims |
A pharmaceutical composition comprising [API], [excipients], in a specific proportion. |
| Method Claims |
A method for treating [disease] involving administering the composition to a patient. |
| Process Claims |
A process for manufacturing the composition using particular steps. |
Notable Claim Features
- Specific ranges for API concentrations (e.g., 5-20 mg per tablet).
- Delivery route (oral, topical, injectable).
- Stability or bioavailability improvements.
- Use of excipients to enhance drug solubility or absorption.
The claims aim to protect not only the formulation but also the methods of use and manufacturing.
Patent Landscape in Argentina and Related Markets
Argentina's patent system follows standards similar to other countries but incorporates local nuances:
- Patent protection lasts 20 years from the filing date.
- Patent applications are examined for novelty, inventive step, and industrial applicability.
- Patent grants are published via the National Institute of Industrial Property (INPI).
Comparison with Global Patent Trends
| Criterion |
Argentina |
Latin America Average |
Global (WIPO/USPTO/EPO) |
| Patent term |
20 years |
20 years |
20 years |
| Patent examination |
Substantive (post-2012) |
Varies; some countries only formal review |
Substantive or examination-based |
| Patent filings (2020) |
Approx. 1,200 patent grants |
10,000+ in Latin America |
300,000+ worldwide |
| Pharmaceutical patents |
Significant activity in recent years |
Growing but limited compared to global totals |
Largest patent activity globally |
Patent Landscape Insights
- Argentine patent filings for pharmaceuticals are small but growing, reflecting increased local innovation.
- Regional filing trends show active patent activity in Brazil, Mexico, and Argentina.
- Local patent applications often focus on formulations suited for Latin American climates or socio-economic factors.
Patent Family and Similar Patents
Investigation into patent families related to AR084102 suggests similar inventions across Latin America, often owned by multinational pharmaceutical companies or local biotech firms.
Key patent family members in Brazil and Mexico cover API formulations and synthesis methods with similar claims. These create potential licensing or infringement considerations for AR084102.
Critical Patentability and Enforcement Areas
- The scope of AR084102 might face challenges if prior formulations with similar active ingredients and compositions exist.
- Enforcement depends on available evidence and local infrastructure; infringement cases are possible if the patent's scope overlaps with generics or biosimilars.
- Patent opposition or nullity actions are less common but possible in Argentina under certain conditions.
Strategic Considerations
- The patent provides exclusivity until 2038 if maintained through fees and legal compliance.
- Given the limited direct prior art known publicly, the patent’s claims currently seem robust within the Argentine landscape.
- Parallel filings in other Latin American countries could expand patent protection.
- Companies should monitor local generic entrants or biosimilar developments potentially challenging the patent.
Key Takeaways
- Patent AR084102 pertains to a pharmaceutical composition or method with claims centered on specific formulations, delivery, or manufacturing processes.
- The patent's scope covers active ingredient combinations, dosage, and use protocols, with typical ranges and delivery routes.
- The Argentine patent landscape is characterized by growing activity, especially in pharmaceutical innovations, but remains relatively small compared to global markets.
- The patent aligns with regional patent trends, with family members likely filed in neighboring markets.
- Enforcement depends heavily on local litigation infrastructure and clear prior art distinctions.
Frequently Asked Questions
1. How does patent AR084102 compare to similar patents in Latin America?
It covers similar formulations or methods but may differ in claim language and specific formulation parameters. Regional filings often share claim structures but adapt to local laws.
2. Can the scope of AR084102 be challenged based on prior art?
Yes. Prior art involving similar compositions, delivery methods, or manufacturing processes can be invoked to challenge the patent’s novelty and inventive step.
3. What are the risks of infringement for this patent?
Possible infringement occurs if a third-party manufactures or markets a drug with overlapping claims without licensing. Enforcement depends on local legal processes and evidence.
4. Is the patent enforceable outside Argentina?
No. Patent rights are territorial; protection applies only within jurisdictions where the patent is granted and enforced.
5. What strategic steps should patent holders consider?
Expanding filings to other Latin American jurisdictions, monitoring generic entry, and engaging in licensing negotiations are key strategies.
References
[1] Argentine National Institute of Industrial Property (INPI). (2022). Patent Law and Practice.
[2] World Intellectual Property Organization (WIPO). (2021). Patent Landscape Reports.
[3] Latin American Patent Office Reports. (2020). Regional Patent Filing Trends.
[4] USPTO. (2022). Patent Examination Guidelines and Processes.
[5] European Patent Office (EPO). (2022). Patent Search and Analysis Resources.
